Get started
222

MEDYSSEY

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

200580 chart


Full chart

Key stats


Market capitalization
‪31.52 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪2.44 B‬ KRW
Revenue (FY)
‪26.56 B‬ KRW
Shares float
—
Beta (1Y)
0.29

Employees


Employees (FY)
96
Change (1Y)
−19 −16.52%
Revenue / Employee (1Y)
‪212.49 K‬ KRW
Net income / Employee (1Y)
‪19.55 K‬ KRW

About MEDYSSEY


Sector
Health Technology
Industry
Medical Specialties
CEO
Jong-Hyun Han
Website
medyssey.co.kr
Headquarters
Jecheon-si
Founded
2003
ISIN
KR7200580009
FIGI
BBG00B6KVC03
Medyssey Co., Ltd. designs, develops, manufactures and markets orthopedic and neurosurgery products. Its products include thoracolumbar stabilization, dynamic stabilization, interbody fusion, cervical, high tibial osteotomy system, pectus excavatum surgery system and trauma. The company was founded on October 14, 2003 and is headquartered in Jecheon-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 200580 is 8,390 KRW — it has decreased by −0.83% in the past 24 hours. Watch MEDYSSEY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange MEDYSSEY stocks are traded under the ticker 200580.
200580 stock has fallen by −3.01% compared to the previous week, the month change is a −15.51% fall, over the last year MEDYSSEY has showed a −20.92% decrease.
200580 reached its all-time high on Nov 4, 2015 with the price of 26,850 KRW, and its all-time low was 3,550 KRW and was reached on Aug 13, 2019. View more price dynamics on 200580 chart.
See other stocks reaching their highest and lowest prices.
200580 stock is 5.56% volatile and has beta coefficient of 0.29. Track MEDYSSEY stock price on the chart and check out the list of the most volatile stocks — is MEDYSSEY there?
Today MEDYSSEY has the market capitalization of ‪30.93 B‬, it has increased by 2.87% over the last week.
Yes, you can track MEDYSSEY financials in yearly and quarterly reports right on TradingView.
No, 200580 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 96.00 employees. See our rating of the largest employees — is MEDYSSEY on this list?
Like other stocks, 200580 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDYSSEY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDYSSEY technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDYSSEY stock shows the strong sell signal. See more of MEDYSSEY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.